(8S)-N-(9H-indeno[2,1-c]pyridin-1-ylmethyl)-N-pentyl-5,6,7,8-tetrahydroquinolin-8-amine
C27H31N3 — CID 159311792
Data last refreshed: (MolForge compound catalog, from PubChem)
About (8S)-N-(9H-indeno[2,1-c]pyridin-1-ylmethyl)-N-pentyl-5,6,7,8-tetrahydroquinolin-8-amine
(8S)-N-(9H-indeno[2,1-c]pyridin-1-ylmethyl)-N-pentyl-5,6,7,8-tetrahydroquinolin-8-amine (PubChem CID 159311792) has the molecular formula C27H31N3 and a molecular weight of 397.57 g/mol. Its IUPAC name is (8S)-N-(9H-indeno[2,1-c]pyridin-1-ylmethyl)-N-pentyl-5,6,7,8-tetrahydroquinolin-8-amine.
Molecular Properties
| Compound Name | (8S)-N-(9H-indeno[2,1-c]pyridin-1-ylmethyl)-N-pentyl-5,6,7,8-tetrahydroquinolin-8-amine |
|---|---|
| PubChem CID | 159311792 |
| Molecular Formula | C27H31N3 |
| Molecular Weight | 397.57 g/mol |
| Exact Mass | 397.25 |
| IUPAC Name | (8S)-N-(9H-indeno[2,1-c]pyridin-1-ylmethyl)-N-pentyl-5,6,7,8-tetrahydroquinolin-8-amine |
| SMILES | CCCCCN(Cc1nccc2c1Cc1ccccc1-2)[C@H]1CCCc2cccnc21 |
| InChI | InChI=1S/C27H31N3/c1-2-3-6-17-30(26-13-7-10-20-11-8-15-29-27(20)26)19-25-24-18-21-9-4-5-12-22(21)23(24)14-16-28-25/h4-5,8-9,11-12,14-16,26H,2-3,6-7,10,13,17-19H2,1H3/t26-/m0/s1 |
| InChIKey | NPYFUNHJFZPZLS-SANMLTNESA-N |
| XLogP | 6.12 |
| TPSA | 29.02 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 397.57 |
| LogP ≤ 5 | 6.12 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159311792 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.